Format

Send to

Choose Destination
Curr Rheumatol Rep. 2011 Aug;13(4):317-23. doi: 10.1007/s11926-011-0188-4.

To what extent can preventive treatments prevent damage from systemic lupus erythematosus?

Author information

1
Harvard Medical School, Center for Clinical Therapeutics, Division of Rheumatology, Brigham and Women's Hospital, Boston, MA 02115, USA. emassarotti@partners.org

Abstract

Managing lupus patients traditionally involves treating manifestations of active disease with the most effective and least toxic therapies so that "damage" from ongoing disease or treatments can be minimized. Damage in clinical epidemiologic studies is usually defined by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index, a validated, organ-specific assessment tool. This review summarizes recent developments regarding organ-specific manifestations and lupus-related damage and their prevention.

PMID:
21611806
DOI:
10.1007/s11926-011-0188-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center